Sai Life Sciences Share Price Target 2025, 2030, 2035, 2040

Sai Life Sciences is one of India’s leading contract research, development, and manufacturing organizations (CRDMOs), providing end-to-end solutions to global pharmaceutical and biotechnology companies. The company focuses on accelerating drug discovery, development, and manufacturing, contributing to the creation of life-saving medicines for patients worldwide. As of December 18, 2024, the Sai Life Sciences share price on the NSE is ₹735. Below are the projected Sai Life Sciences share price target for the years 2024, 2025, 2026, 2027, 2030, 2035 And 2040.

Additionally, feel free to join our – Tele-(g)ram) where we share Fast stock market news and updates➥https://bit.ly/TradeWatch360

Sai Life Sciences Company Overview

Founded in 1999 and headquartered in Hyderabad, Sai Life Sciences specializes in offering customized solutions across the pharmaceutical lifecycle. Its services include drug discovery, process development, clinical and commercial manufacturing, and supply chain management. The company collaborates with some of the world’s top pharmaceutical innovators, enabling faster development of new therapies.

Company type	Private
Traded as	NSE: SAILIFE BSE: 544306
ISIN	INE118H01025
Industry	Healthcare
Founded	1999; 25 years ago
Headquarters	Hyderabad, India
Area served	Worldwide
Key people	Krishnam Raju Kanumuri (CEO & MD) Ramesh Ganesh Iyer (ID) Mitesh Daga (ED)
Services	Research,  Development,  Manufacturing of small-molecule new chemical entities
Revenue	₹1,465 Cr (FY24)
Net income	₹83 Cr (FY24)
Total assets	₹2477 Cr (FY24)
Number of employees	2845 (2024)
Website	www.sailife.com

Sai Life Sciences Share Price Target 2025-2040 Forecast

Year	Year High Target	Year Low Target
2024	₹760	₹550
2025	₹950	₹620
2026	₹1100	₹700
2027	₹1220	₹850
2028	₹1300	₹940
2029	₹1450	₹1050
2030	₹1700	₹1300
2035	₹3150	₹1450
2040	₹5750	₹2500

Technical Analysis for Sai Life Sciences

Sai Life Sciences Share Price Target 2025

Year	1st Target	2nd Target
2025	860	950

Sai Life Sciences is a leading company specializing in pharmaceutical research and development services. In 2025, the company is expected to show strong growth, driven by its expertise in providing end-to-end drug discovery and development solutions to its global clients. The first share price target for 2025 is ₹860, while the second target is ₹950, reflecting its growing reputation and expanding market presence.

Read More:- Waaree Energies Share Price Target 2025, 2030, 2035, 2040

Sai Life Sciences Share Price Target 2026

Year	1st Target	2nd Target
2026	1030	1100

By 2026, Sai Life Sciences is projected to build on its innovative research and development capabilities, especially in supporting life sciences companies worldwide. With increasing demand for drug discovery and contract development services, the first target share price for 2026 is estimated at ₹1,030, and the second target at ₹1,100, signaling steady growth.

Sai Life Sciences Share Price Target 2027

Year	1st Target	2nd Target
2027	1150	1220

In 2027, Sai Life Sciences is expected to leverage its robust expertise in pharmaceutical services, which could lead to significant growth. The share price is projected to reach ₹1,150 as the first target and ₹1,220 as the second target. Its commitment to delivering high-quality solutions to its clients is likely to enhance its market value further.

Sai Life Sciences Share Price Target 2028

Year	1st Target	2nd Target
2028	1250	1300

Sai Life Sciences is anticipated to achieve further milestones by 2028 as it continues to expand its global footprint and strengthen its portfolio in drug discovery and development. The first share price target for 2028 is forecasted at ₹1,250, while the second target is ₹1,300, highlighting consistent progress.

Sai Life Sciences Share Price Target 2029

Year	1st Target	2nd Target
2029	1400	1450

In 2029, Sai Life Sciences is expected to continue benefiting from the increasing demand for its innovative pharmaceutical solutions. The first target share price for this year is projected at ₹1,400, with the second target at ₹1,450, showcasing its steady performance and adaptability to changing market needs.

Sai Life Sciences Share Price Target 2030

Year	1st Target	2nd Target
2030	1600	1700

Looking toward 2030, Sai Life Sciences is likely to solidify its position as a leader in the life sciences sector, thanks to its continued investment in research and technological advancements. The first target share price for 2030 is ₹1,600, and the second target is ₹1,700, reflecting its potential for sustained growth.

Sai Life Sciences Share Price Target 2035

Year	1st Target	2nd Target
2035	2500	3150

By 2035, Sai Life Sciences is expected to achieve significant growth, driven by its ability to cater to the increasing demand for pharmaceutical services globally. The first share price target for this year is ₹2,500, with the second target at ₹3,150, showcasing its long-term potential as a key player in the industry.

Read More:- FCS Software Share Price Target 2025, 2030, 2035, 2040

Sai Life Sciences Share Price Target 2040

Year	1st Target	2nd Target
2040	4500	5750

Fast-forwarding to 2040, Sai Life Sciences is poised to become a major force in the pharmaceutical services market, supported by its innovative approach and commitment to excellence. The first target share price for 2040 is ₹4,500, with the second target at ₹5,750, indicating substantial long-term value creation for its investors.

Sai Life Sciences Fundamentals

Parameter	Value
Market Cap	₹11,419 Cr
P/E Ratio (TTM)	0.00
P/B Ratio	0.00
Industry P/E	74.16
Debt to Equity	0.95
ROE	0.00%
EPS (TTM)	4.34
Dividend Yield	0.00%
52 Week High	₹764
52 Week Low	₹549
Book Value	51.19
Face Value	1

Sai Life Sciences Financial Results

All In ₹Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	760	870	1,217	1,465
Expenses	593	743	1,048	1,178
Operating Profit	167	126	169	287
OPM %	22%	15%	14%	20%
Other Income	27	28	27	29
Interest	33	54	81	88
Depreciation	80	90	99	119
Profit before tax	82	10	16	109
Tax %	25%	36%	39%	24%
Net Profit	61	6	10	83
Dividend Payout %	0%	1,117%	676%

Sai Life Sciences Balance Sheet

All In ₹Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	17	18	18	18	19
Reserves	845	861	870	957	1,027
Borrowings	637	752	933	929	992
Other Liabilities	318	527	358	359	439
Total Liabilities	1,817	2,157	2,179	2,262	2,477
Fixed Assets	701	751	1,037	1,180	1,228
CWIP	246	410	151	107	152
Investments	0	0	2	2	2
Other Assets	870	997	989	973	1,095
Total Assets	1,817	2,157	2,179	2,262	2,477

Sai Life Sciences Shareholding Pattern

	Sep 2024
Promoters	39.64%
FIIs	0.00%
DIIs	0.00%
Public	60.36%

Sai Life Sciences Peer comparison

Sector: Healthcare			Industry: Miscellaneous
Name	P/E	Mar Cap₹Cr.	Div Yld%	NP Qtr₹Cr.	ROCE%
Syngene Intl.	75.02	34598.05	0.15	106.10	14.74
Indegene	38.78	14387.26	0.00	91.70	29.02
Sai Life	137.91	11418.63		28.01	10.57
Suven Life Scie.		3128.29	0.00	-49.64	-36.37
Vimta Labs	44.16	2246.79	0.20	14.59	16.82
Kaya Ltd		484.61	0.00	-15.67	-80.45
Jeevan Scienti.	1309.21	78.56	0.00	0.25	-1.03

FAQs

Q.1. What is the share price target for Sai Life sciences in 2025?

Ans: By 2025, Sai Life Sciences could reach ₹860 and might climb to ₹950. This growth comes as the company focuses on cost-effective services in areas like healthcare and education.

Q.2. What is the share price target for Sai Life sciences in 2026?

Ans: In 2026, the share price may rise to ₹1030 and even ₹1100. Their global expansion and innovative solutions are likely to drive this progress.

Q.3. What is the share price target for Sai Life sciences in 2027?

Ans: By 2027, Sai Life Sciences could hit ₹1150 and may go up to ₹1220. The growing demand for IT services and their expertise in delivering quality solutions will likely fuel this growth.

Q.4. What is the share price target for Sai Life sciences in 2028?

Ans: For 2028, the share price is projected to touch ₹1250, with potential to reach ₹1300. The company’s focus on emerging technologies is expected to contribute to steady growth.

Q.5. What is the share price target for Sai Life sciences in 2029?

Ans: By 2029, Sai Life Sciences might see its shares valued at ₹1400 and possibly ₹1450. Their innovative approach and a stronger portfolio of services are expected to keep them competitive.

Q.6. What is the share price target for Sai Life sciences in 2030?

Ans: In 2030, the company’s share price could grow significantly to ₹1600 and even ₹1700. Sai Life Sciences’ scalable and efficient solutions are likely to strengthen its market position.

Q.7. What is the share price target for Sai Life sciences in 2035?

Ans: By 2035, the company could achieve a share price of ₹2500, with the potential to go as high as ₹3150. This reflects its long-term commitment to innovation and industry leadership.

Q.8. What is the share price target for Sai Life sciences in 2040?

Ans: Looking forward to 2040, Sai Life Sciences might see exponential growth with shares valued at ₹4500 to ₹5750. Their focus on advanced technologies and global presence could help them become a major player in the industry.

Q.9. Who is the current CEO of Sai Life Sciences?

Ans: The current CEO of Sai Life Sciences is Srinivas S. He has been leading the company with a vision to drive growth and innovation in the pharmaceutical and biotechnology sectors.

Q.10. What are the NSE and BSE codes for Sai Life Sciences?

Ans: The NSE code for Sai Life Sciences is SAILIFE and the BSE code is 544306. These codes can be used to track its stock performance on the respective exchanges.